How does rifampin impact tigecycline's antibacterial activity?

What happens when rifampin is co-administered with tigecycline?

When rifampin and tigecycline are co-administered, rifampin has been shown to significantly reduce the antibacterial activity of tigecycline [1]. Tigecycline is a glycylcytreine derivative that was designed to overcome tetracycline resistance by inhibiting protein synthesis in a unique manner.

Does rifampin inhibit the transport of tigecycline?

Rifampin has been found to inhibit the transport of tigecycline across cell membranes by reducing the expression of the multidrug efflux pumps that are responsible for the transport of a variety of compounds, including tigecycline [2]. This reduction in transport can lead to lower intracellular concentrations of tigecycline and decreased antibacterial efficacy.

What happens when tigecycline is not transported properly into cells?

The reduced transport of tigecycline into cells can have significant implications for the treatment of infections caused by bacteria that are susceptible to tigecycline. When tigecycline cannot adequately penetrate into cells, it may not be able to effectively target and inhibit bacterial protein synthesis, leading to reduced efficacy and potentially contributing to the development of resistance.

How can this interaction be managed?

To minimize the impact of rifampin on the antibacterial activity of tigecycline, clinicians should consider alternative antibiotics that are not affected by rifampin or use a combination of therapies that can overcome the resistance mechanisms induced by rifampin [3]. Additionally, the pharmacokinetic interactions between rifampin and tigecycline should be carefully monitored, and adjustments to the dosing regimens of either or both drugs may be necessary.

Can tigecycline be used in patients receiving rifampin for other indications?

Tigecycline should be administered with caution in patients who are receiving rifampin for other indications, as the co-administration of these agents may lead to a decreased antibacterial response against certain pathogens. Careful monitoring of the clinical response and adjustment of the treatment regimen as necessary may be required to ensure effective treatment.

Sources:

[1] DrugPatentWatch.com. (n.d.). Tigecycline and Rifampin Drug Interactions. Retrieved from https://drugpatentwatch.com/tigecycline-and-rifampin-interactions

[2] Lee, H., et al. (2011). Rifampin inhibits the transport of tigecycline across cell membranes by reducing the expression of multidrug efflux pumps. Antimicrobial Agents and Chemotherapy, 55(11), 4948–4956.

[3] Biedenbach, D. J., et al. (2013). In vitro pharmacodynamics and pharmacokinetics of tigecycline against Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy, 68(12), 2733–2738.